Chief Executive Officer
Larry Jasinski has served as Chief Executive Officer and as a member of the ReWalk board since February 2012. From 2005 until 2012, Mr. Jasinski served as the President and Chief Executive Officer of Soteira, Inc., a company engaged in development and commercialization of products used to treat individuals with vertebral compression fractures, which was acquired by Globus Medical in 2012. From 2001 to 2005, Mr. Jasinski was President and Chief Executive Officer of Cortek, Inc., a company that developed next-generation treatments for degenerative disc disease, which was acquired by Alphatec in 2005. From 1985 until 2001, Mr. Jasinski served in multiple sales, research and development, and general management roles at Boston Scientific Corporation. Mr. Jasinski holds a B.Sc. in marketing from Providence College and an MBA from the University of Bridgeport.
Executive Advisor to the CEO
Ami Kraft joined the company in 2010. Mr. Kraft has been appointed as Executive Advisor to the CEO as of October 2017. Mr. Kraft previously served the company as President of ReWalk Robotics since August 2016, Senior Vice President from July 2015, and General Manager of ReWalk Robotics Ltd. in Israel since January 1, 2015. These positions are following his six-year tenure as our Chief Financial Officer, including the successful IPO in 2014. Before joining ReWalk, Mr. Kraft served as the Chief Financial Officer of various international technology companies, including PicScout, which was bought by Getty Images while he was serving as CFO, IC4IC, Zoran Corporation, where he was actively involved in their IPO, and Kulicke & Soffa Inc., where he served for over 20 years. Mr. Kraft holds a B.A. in public accounting from Haifa University and an MBA from Stanford University.
Chief Financial Officer
Kevin Hershberger joined as Chief Financial Officer in January 2015. Before joining ReWalk, he served as Vice President, Controller and Chief Accounting Officer at NxStage Medical Inc., a Nasdaq-listed manufacturer of innovative dialysis products. During his over six-year tenure, Mr. Hershberger led the financial operations, improved gross margins, participated in fund-raising activities, and established a joint venture manufacturing operation in Germany. Prior to NxStage, Mr. Hershberger worked for nearly ten years in positions of increasing responsibility at Boston Scientific Corporation (NYSE: BSX), a global developer, manufacturer and distributor of less invasive medical devices, ultimately serving as Controller/Director Finance—Urology & Gynecology. Mr. Hershberger began his career as an accountant at the USG Corporation, a global manufacturer and distributor of building materials. Mr. Hershberger is a graduate of West Virginia University with a Bachelors of Science degree in accounting, and a Company Commander in the U.S. Army Reserves.
General Manager Israel;
Vice President of R&D and Regulatory
Ofir Koren joined the company in February 2013 and serves as General Manager of Israel and Vice President of Research & Development and Regulatory. From 2009 to 2013, Mr. Koren served as General Manager of RuggedCOM Israel, a developer of communications equipment. From 2007 to 2009, he served as the Vice President of Research and Development of Alvarion Technologies Ltd., an Israeli provider of wireless services. Mr. Koren holds a B.Sc. in electrical engineering from Tel Aviv University and an MBA from the University of Herriot Watt.
Vice President of QA and Operations
Miri Pariente joined the company in April 2013 and serves as Vice President of Quality Assurance and as Vice President of Operation. From 2012 to 2013, Ms. Pariente was the Manager of Quality Assurance at NLT Spine Ltd., a developer of minimally invasive spine procedures, and, from 2011 to 2012, was the Manager of Quality Assurance at ProAccess Medical Ltd. From 2002 to 2010, Ms. Pariente served in multiple roles within American Medical Systems including Production Supervisor and Lean Leader. Ms. Pariente holds a B.A. in business management from Derby University.